Vistin Pharma ASA VISTN

OSL: VISTN | ISIN: NO0010734122   1/10/2026
18,25 NOK (-1,35%)
(-1,35%)   1/10/2026

20 augustus 2026 · Vistin Pharma ASA: Second quarter and YTD 2026 financial results · Persbericht

13 augustus 2026 · Vistin Pharma ASA: Invitation to Q2 2026 conference call · Persbericht

22 mei 2026 · Ex dividend NOK 1.00 today · Persbericht

20 mei 2026 · Vistin Pharma ASA: Minutes from the annual general meeting 2026 · Persbericht

20 mei 2026 · Disclosure of voting rights at AGM in Vistin Pharma ASA · Persbericht

28 april 2026 · Vistin Pharma ASA: Notice of Annual General Meeting 20 May 2026 · Persbericht

24 april 2026 · 2025 Annual Report Vistin Pharma ASA · Persbericht

24 april 2026 · Vistin Pharma ASA: First quarter 2026 financial results · Persbericht

17 april 2026 · Vistin Pharma ASA: Invitation to Q1 2026 conference call · Persbericht

20 februari 2026 · Vistin Pharma ASA: Mandatory notification of trade · Persbericht

12 februari 2026 · Vistin Pharma ASA (VISTN): Key information relating to the proposed cash dividend · Persbericht

12 februari 2026 · Vistin Pharma ASA: Fourth quarter and preliminary 2025 financial results · Persbericht

5 februari 2026 · Vistin Pharma ASA (VISTN): Invitation to Q4 2025 conference call · Persbericht

31 oktober 2025 · Vistin Pharma ASA: Third quarter and YTD 2025 financial results · Persbericht

24 oktober 2025 · Vistin Pharma ASA: Invitation to Q3 2025 conference call · Persbericht

15 augustus 2025 · Vistin Pharma ASA: Second quarter and YTD 2025 financial results · Persbericht

8 augustus 2025 · Vistin Pharma ASA: Invitation to Q2 2025 conference call · Persbericht

4 juni 2025 · Ex dividend NOK 1.25 today · Persbericht

22 mei 2025 · Vistin Pharma ASA: Minutes from the annual general meeting 2025 · Persbericht

22 mei 2025 · Disclosure of voting rights at AGM in Vistin Pharma ASA · Persbericht

Mijn selecties